FCF YoY
+19.81%
OCF YoY
+13.88%
Capex YoY
-4.26%
FCF Conversion Δ
+3.9 pp
Free cash flow bridge for Boston Scientific (BSX) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: $569.00M
FCF bridge breakdown for Boston Scientific (BSX) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $2.87B | — |
| Operating Cash Flow | $529.00M | +93.0% |
| Capital Expenditure | $40.00M | +7.0% |
| Free Cash Flow | $3.44B | — |
- Prior Free Cash Flow$2.87B
- Operating Cash Flow$529.00M
- Capital Expenditure$40.00M
- Free Cash Flow$3.44B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement